Physician profile
Praveen Kumar
NPI 1043264872
$778.27
in general payments reported to CMS, 2019-2025
8 companies · $165 in 2025
The $165 reported for 2025 was more than what 79% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.08 · 2020: $43.22 · 2021: $59.67 · 2022: $310 · 2023: $34.52 · 2024: $81.82 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ony Biotech INC. | $191.39 | 2022 | |
| Glaxosmithkline, LLC. | $190.36 | 2019-2024 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $146.91 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Biocodex, INC. | $146.75 | 2025 | |
| Sanofi Pasteur INC. | $58.74 | 2021-2022 | |
| Abbott Laboratories | $26.52 | 2022 | |
| Mallinckrodt Enterprises LLC | $17.60 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praveen Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.